William F. Doyle
2020
In 2020, William F. Doyle earned a total compensation of $15.7M as Executive Chairman at NovoCure, a 90% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,053,000 |
|---|---|
| Salary | $772,500 |
| Stock Awards | $13,893,701 |
| Other | $4,500 |
| Total | $15,723,701 |
Doyle received $13.9M in stock awards, accounting for 88% of the total pay in 2020.
Doyle also received $1.1M in non-equity incentive plan, $772.5K in salary and $4.5K in other compensation.
Rankings
In 2020, William F. Doyle's compensation ranked 369th out of 13,090 executives tracked by ExecPay. In other words, Doyle earned more than 97.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 369 out of 13,090 | 97th |
Division Manufacturing | 126 out of 5,624 | 98th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 9 out of 799 | 99th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 4 out of 495 | 99th |
Industry Surgical and Medical Instruments and Apparatus | 4 out of 313 | 99th |
Source: SEC filing on April 27, 2021.
Doyle's colleagues
We found five more compensation records of executives who worked with William F. Doyle at NovoCure in 2020.